{
    "organizations": [],
    "uuid": "78ff8cb3f4ee0598f4b127868f0d39ccad162351",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ophthotech-targets-gene-therapy-to/brief-ophthotech-targets-gene-therapy-to-expand-its-orphan-and-age-related-retinal-disease-strategy-idUSFWN1QH0QH",
    "ord_in_thread": 0,
    "title": "BRIEF-Ophthotech Targets Gene Therapy To Expand Its Orphan And Age-Related Retinal Disease Strategy",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 27 (Reuters) - Ophthotech Corp:\n* OPHTHOTECH TARGETS GENE THERAPY TO EXPAND ITS ORPHAN AND AGE-RELATED RETINAL DISEASE STRATEGY\n* OPHTHOTECH - ‍ENTERED SERIES OF SPONSORED RESEARCH AGREEMENTS WITH UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL AND ITS HORAE GENE THERAPY CENTER​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-27T19:39:00.000+02:00",
    "crawled": "2018-02-28T13:07:09.055+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "ophthotech",
        "corp",
        "ophthotech",
        "target",
        "gene",
        "therapy",
        "expand",
        "orphan",
        "retinal",
        "disease",
        "strategy",
        "ophthotech",
        "series",
        "sponsored",
        "research",
        "agreement",
        "university",
        "massachusetts",
        "medical",
        "school",
        "horae",
        "gene",
        "therapy",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}